Kidney Cancer Clinical Trial
Biomarkers of Renal Dysfunction in Neuroblastoma Survivors
Summary
The main purpose of this study is to learn more about biomarkers of kidney function in the blood and urine of neuroblastoma survivors. A biomarker is a biological molecule found in blood, urine, other body fluids, or tissues that is a sign of a normal or abnormal process, or of a condition or disease. A biomarker may be used to see how well the body responds to a treatment for a disease or condition.
Eligibility Criteria
Inclusion Criteria:
Diagnosis of neuroblastoma between 0-18 years of age
< 21 years of age at time of study enrollment
Two or more years from completion of systemic chemotherapy and/or radiation therapy
Exclusion Criteria:
Patients treated with observation only
Patients with multiple primary cancers
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
New York New York, 10065, United States
How clear is this clinincal trial information?
